Health
Johnson & Johnson trials show single-shot COVID-19 vaccine effective; hoping for emergency use OK soon – WSOC Charlotte
A COVID-19 vaccine produced by Johnson & Johnson is provoking an immune response in human trials and is showing it is effective in fighting the virus that has killed…

Studies on the companys one-dose vaccine showed it would produce neutralizing antibodies, or antibodies that fight the virus, soon after the drug was administered.
The vaccine was being tested on people aged 18-55. While common side effects of a vaccination — such as fever, fatigue, headache, and pain at the injection site — were seen in some people, those side effects were not severe.
Dr. Paul Stoffels, chief scientific officer at J&J, said the data gave the company confidence the vaccine will…
-
General19 hours ago
Of saints and sinners | The Spectator Australia
-
General20 hours ago
Small plane crashes into San Diego neighbourhood, setting homes and vehicles on fire
-
Noosa News10 hours ago
Tully Sugar Mill celebrates 100 years of cane harvesting amid floods and cyclones
-
General20 hours ago
Why the nation needs the Nationals to ditch Net Zero